This page reprints a manufacturer label. Everything below in quotation marks is copied from MuTian, Xraphconn, 200mg *20 tablets, published by FDA and retrieved on 2026-09-16. Nothing has been added, reworded or left out of the sections shown. It is the manufacturer’s label, reproduced as published.
This page reprints the FDA label for MuTian, Xraphconn, 200mg *20 tablets by Nantong MUTIAN Biotechnology Co., Ltd, a scrophularia ningpoensis root product labelled for cats. The sections below are copied from that label without change, with the set id and the date it was retrieved from DailyMed.
The label
Product: MuTian, Xraphconn, 200mg *20 tablets. Manufacturer: Nantong MUTIAN Biotechnology Co., Ltd. FDA Structured Product Label set id c09b3f95-0f1d-4852-bed8-7731a7404d02. Label effective 2020-10-17. Retrieved 2026-09-16 from the DailyMed animal label release, and readable on DailyMed.
Indications
Xraphconn tablet is used to treat cats suffering from various forms of feline infectious peritonitis (FIP).
Dosage and Administration
The daily dose for Xraphconn is 100mg/kg of body weight. This product is recommended to take on an empty stomach. Consult your veterinarian for help in the diagnosis, treatment and control of FIP. Active Ingredient Radix scrophulariae 35% Inactive Ingredients Platycodon grandiflorum Phyllostachys pubescens Forsythia suspensa Anemarrhena asphodeloides Keep this and all medications out of reach of children and pets.
Warnings
FOR USE IN CATS ONLY Not for use in humans. For use in cats only. Keep this and all medications out of reach of children and pets. Consult a physician in case of accidental ingestion by humans. The safe use of Xraphconn has not been evaluated in cats used for breeding or pregnant or lactating females.
Storage
Store in a dry, cool place at temperatures not above 25℃ (77℉). Package Label - Principal Display Panel Outer Package Label
FDA adverse event reports
The FDA Center for Veterinary Medicine publishes the adverse event reports it receives through openFDA. The counts below are the reports naming scrophularia ningpoensis root as an active ingredient for each species this label names, as returned on 2026-09-16, coded by the VeDDRA reaction term the reporter chose. Reactions are counted per report, so one report can appear under several terms.
These are counts, not rates. Reporting is voluntary, the number of animals treated is not known, and a widely used product accumulates reports for that reason alone. A report records that an event followed a dose; it does not establish that the product caused it. The counts say nothing about how one product compares with another.
Cats: 0 reports
openFDA returned no reports for this ingredient in cats on 2026-09-16.
Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.
Sources
- MuTian, Xraphconn, 200mg *20 tabletsFDA · retrieved 2026-09-16
“The daily dose for Xraphconn is 100mg/kg of body weight.” (Dosage and Administration)
- openFDA Animal and Veterinary Adverse Event ReportsFDA · retrieved 2026-09-16
Related
From Glarda
The note drafted from the consult, with the reference you just read sitting beside it in the shape your record already expects.